Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Shanghai Kindly Medical Instruments Co., Ltd. Class H ( (HK:1501) ).
Shanghai INT Medical Instruments Co., Ltd. has called its annual general meeting for 28 May 2026 in Shanghai, where shareholders will review reports from the board and supervisory committee, the 2025 annual report, audited group financial statements, the 2025 profit distribution plan and the 2026 financial budget. The AGM will also vote on director remuneration, reappointing KPMG and KPMG Huazhen LLP as international and domestic auditors, and granting a mandate allowing the board to repurchase up to 10% of H shares and domestic shares and to cancel them, which could affect capital structure and shareholder value.
If approved, the share repurchase mandate would give the directors flexibility to time market operations, manage the company’s equity base and adjust its articles of association accordingly. These decisions collectively will shape the company’s capital allocation, governance arrangements and financial oversight in the coming year, with implications for investors’ returns and the group’s standing in the competitive medical device industry.
More about Shanghai Kindly Medical Instruments Co., Ltd. Class H
Shanghai INT Medical Instruments Co., Ltd. is a PRC-incorporated medical device manufacturer listed in Hong Kong, focusing on producing and selling medical instruments and related products. The company operates through a group structure and serves both domestic and international markets, relying on external auditors for its financial reporting and compliance in the healthcare sector.
Average Trading Volume: 265,736
Technical Sentiment Signal: Buy
Current Market Cap: HK$8.23B
For an in-depth examination of 1501 stock, go to TipRanks’ Overview page.